Browsing by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 29281 to 29300 of 77249

This table browses all dspace content
Issue DateTitleJournal Title
2013Layered Voice Analysis 프로그램을 활용한 음성장애 환자의 스트레스 파라메터와 음성장애지수 간의 상관관계Thesis
2019Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 studyLANCET ONCOLOGY
2023Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter studyLUNG CANCER
2023Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301JOURNAL OF CLINICAL ONCOLOGY
2023Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301 JOURNAL OF THORACIC ONCOLOGY
2022Lazertinib: on the Way to Its Throne YONSEI MEDICAL JOURNAL
2019LBA1_PR - Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 studyANNALS OF ONCOLOGY
2019LBA4 - Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the Phase 3 MYSTIC studyANNALS OF ONCOLOGY
2022LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)ANNALS OF ONCOLOGY
2021LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritisEXPERT OPINION ON BIOLOGICAL THERAPY
2021LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells AUTOPHAGY
2021LCCL peptide cleavage after noise exposure exacerbates hearing loss and is associated with the monocyte infiltration in the cochleaHEARING RESEARCH
2002LCM positive 환자에서 plasmapheresis, IV gamma globulin 및 면역억제제를 병용하여 LCM 음성전환후 시행한 신장이식의 결과 Journal of the Korean Society for Transplantation
2014LD50 추정을 위한 방법론 비교 Thesis
2005LDA와 SVM 기반의 심실세동 검출에 관한 연구 Thesis
2018LDB2 regulates the expression of DLL4 through the formation of oligomeric complexes in endothelial cells BMB REPORTS
2014LDL Cholesterol Affects Clinical Outcomes in Incident Hemodialysis Patients During the Early Stages of DialysisBLOOD PURIFICATION
2005LDL 콜레스테롤 유전율과 유전자 분리모형 연구 KOREAN CIRCULATION JOURNAL
1999LDL-콜레스테롤 상승 환자에 대한 Atorva-statin의 유효성 및 안전성에 대한 연구 Korean Circulation Journal (순환기)
2000LDL-콜레스테롤 수준의 추정된 주유전자(putative major gene)에 관한 연구: 유전자 분리모형(segregation analysis)Korean Journal of Epidemiology

Browse

Links